Ellomay Capital director granted 1,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ellomay Capital Ltd. director Gilad Mamlok received an annual grant of stock options on August 1, 2026 under the 1998 Share Option Plan for Non-Employee Directors. The award covers 1,000 options to buy 1,000 Ordinary Shares at an exercise price of 19.60 per share, becoming exercisable on August 1, 2027 and expiring on August 1, 2036, subject to his continued board service on the exercise date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1, F2 | 1,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. On August 1, 2026, the Reporting Person received an annual grant of options under the terms and conditions set forth in the Issuer's 1998 Share Option Plan for Non-Employee Directors.
- F2. Subject to the Reporting Person serving as a member of the Issuer's Board of Directors on such date.
Key Figures
Key Terms
Stock Option (right to buy) financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Gilad Mamlok report for Ellomay Capital (ELLO)?
How many stock options were granted to Gilad Mamlok in Ellomay Capital (ELLO)?
What is the exercise price of Gilad Mamlok’s ELLO stock options and what do they cover?
When do Gilad Mamlok’s Ellomay Capital (ELLO) options vest and when do they expire?
Are Gilad Mamlok’s ELLO stock options subject to any service condition?
Was the reported Ellomay Capital (ELLO) Form 4 transaction under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.